Companies › OpenEvidence
OpenEvidence logo

OpenEvidence

Cambridge, US · founded 2021 · ~120 employees · Software Publishers · Crunchbase rank #56 · openevidence.com

OpenEvidence provides an artificial intelligence medical information platform that organizes and synthesizes peer-reviewed clinical research to help physicians access evidence-based insights for clinical decision support. Its products include an AI-powered medical search engine that quickly retrieves and cites relevant literature from major journals and tools like DeepConsult that generate comprehensive research syntheses for complex clinical questions. The platform also integrates features that support clinical documentation and evidence retrieval during patient encounters, aiming to streamline how healthcare professionals find and apply clinical evidence. OpenEvidence delivers responses grounded in sourced medical research and supports workflows that assist clinicians in evaluating and interpreting medical knowledge.

Also: software development · medical evidence delivery · clinical decision support tools · medical literature synthesis tools · clinical decision support platforms · ai in healthcare · clinical decision-making ai · healthcare digital transformation · patient care · medical research synthesis · ai in clinical practice · medical literature platform

Funding

2
Every round, secondary, debt facility or acquisition involving OpenEvidence that AI Lounge tracks, newest first. Latest: Series E on Sep 16, 2026.
OpenEvidence logo
Investors not disclosed · Clinical Trials
$250M
OpenEvidence logo
$250M
val. $12B

Timeline · 4

Sep 16, 2026
Round
Sep 16, 2026
Deal
Jan 21, 2026
Round
Series D · $250M at $12B · Thrive Capital, DST Global

In the news

2
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in